These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29766267)

  • 1. [Syncopes and channelopathies].
    Müller-Leisse J; Zormpas C; König T; Duncker D; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2018 Jun; 29(2):171-177. PubMed ID: 29766267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of syncope as a presenting symptom in channelopathies diagnosed in childhood. Can the multivariable EGSYS score unmask these children?
    Környei L; Szabó A; Róth G; Kardos A; Fogarasi A
    Eur J Pediatr; 2021 May; 180(5):1553-1559. PubMed ID: 33447893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic complications of genetic channelopathies.
    Franklin WH; Laubham M
    Handb Clin Neurol; 2021; 177():185-188. PubMed ID: 33632437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Channelopathies That Lead to Sudden Cardiac Death: Clinical and Genetic Aspects.
    Skinner JR; Winbo A; Abrams D; Vohra J; Wilde AA
    Heart Lung Circ; 2019 Jan; 28(1):22-30. PubMed ID: 30389366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recognizing rare cardiac diseases by electrocardiogram].
    Grimm W; Grimm A; Grimm K; Efimova E
    Internist (Berl); 2018 Jun; 59(6):618-629. PubMed ID: 29619572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac channelopathies in the context of hereditary arrhythmia syndromes].
    Huttelmaier MT; Fischer TH
    Inn Med (Heidelb); 2024 Aug; 65(8):787-797. PubMed ID: 38977442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Why do we need genetics in cardiac rhythmology?].
    Rieder M; Castiglione A; Asatryan B; Odening KE
    Herzschrittmacherther Elektrophysiol; 2020 Dec; 31(4):394-400. PubMed ID: 32661562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sudden cardiac death in athletes with an apparently normal heart: the channelopathies].
    Giustetto C; Gaita F
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):78S-82S. PubMed ID: 19195312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable defibrillators versus medical therapy for cardiac channelopathies.
    McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Singh M; Morin DP; Link MS
    Prog Cardiovasc Dis; 2019; 62(3):227-234. PubMed ID: 31078562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Channelopathies: Recognition, Treatment, Management.
    Hickey KT; Elzomor A
    AACN Adv Crit Care; 2018; 29(1):43-57. PubMed ID: 29496713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
    Napolitano C; Bloise R; Monteforte N; Priori SG
    Circulation; 2012 Apr; 125(16):2027-34. PubMed ID: 22529064
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudden death and ion channel disease: pathophysiology and implications for management.
    Bastiaenen R; Behr ER
    Heart; 2011 Sep; 97(17):1365-72. PubMed ID: 21685181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies.
    Tonko JB; Lambiase PD
    Cardiovasc Res; 2024 Mar; 120(2):114-131. PubMed ID: 38195920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pharmacotherapy in cardiac ion channelopathies.
    El-Sherif N; Boutjdir M
    Pharmacol Ther; 2015 Nov; 155():132-42. PubMed ID: 26376080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic channelopathy syndromes presenting as refractory epilepsy.
    Hazle MA; Shellhaas RA; Bradley DJ; Dick M; Lapage MJ
    Pediatr Neurol; 2013 Aug; 49(2):134-7. PubMed ID: 23859862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic cardiac innervation: impact on the evolution of arrhythmias in inherited cardiac arrhythmia syndromes.
    Maury P; Delasnerie H; Beneyto M; Rollin A
    Herzschrittmacherther Elektrophysiol; 2021 Sep; 32(3):308-314. PubMed ID: 34185133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited Cardiac Arrhythmias and Channelopathies.
    Kline J; Costantini O
    Med Clin North Am; 2019 Sep; 103(5):809-820. PubMed ID: 31378327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.